Announcement
19 Oct 2021
On 19 October 2021, the EIB provided financing worth EUR 45 million (USD 52 million) to support Spanish company HIPRA in the development of a new COVID-19 vaccine.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
19 Oct 2021
Revocation date:
No revocation date
Updated: 19 Oct 2021
State loan
In force
On 19 October 2021, the European Investment Bank (EIB) and Spanish company Laboratorios HIPRA SA signed a loan agreement worth EUR 45 million (approx. USD 52 million) to support HIPRA in the developme...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.